首页> Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology> Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.

Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.

导出 OA

翻译打印收藏纠错

第一作者： Minh Tung,Phung

第一单位： Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.

作者： Minh Tung,Phung ^[1] ; Alice W,Lee ^[2] ; Anna H,Wu ^[3] ; Andrew,Berchuck ^[4] ; Kathleen R,Cho ^[5] ; Daniel W,Cramer ^[6] ; Jennifer Anne,Doherty ^[7] ; Marc T,Goodman ^[8] ; Gillian E,Hanley ^[9] ; Holly R,Harris ^[10] ; Karen,McLean ^[11] ; Francesmary,Modugno ^[12] ; Kirsten B,Moysich ^[13] ; Bhramar,Mukherjee ^[14] ; Joellen M,Schildkraut ^[15] ; Kathryn L,Terry ^[6] ; Linda J,Titus ^[16] ; Susan J,Jordan ^[17] ; Penelope M,Webb ; Malcolm C,Pike ; Celeste Leigh,Pearce ; Ovarian Cancer Association Consortium ; Australian Ovarian Cancer Study Group and the Ovarian Cancer Association Consortium ; Ovarian Cancer Association Consortium

作者单位： Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan. ^[1] Department of Public Health, California State University, Fullerton, Fullerton, California. ^[2] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. ^[3] Division of Gynecologic Oncology, Duke University School of Medicine, Durham, North Carolina. ^[4] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan. ^[5] Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts.;Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. ^[6] Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah. ^[7] Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, California. ^[8] Department of Obstetrics and Gynecology, University of British Columbia Faculty of Medicine, Vancouver, Canada. ^[9] Division of Public Health Sciences, Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington. ^[10] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan. ^[11] Women's Cancer Research Center, Magee-Women's Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.;Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. ^[12] Division of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York. ^[13] Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.;Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan. ^[14] Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia. ^[15] University of Queensland, School of Public Health, Brisbane, Queensland, Australia. ^[16] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.;Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. ^[17]

医学主题词成年人(Adult);病例对照研究(Case-Control Studies);女(雌)性(Female);人类(Humans);醋酸甲羟孕酮(Medroxyprogesterone Acetate);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);孕激素类(Progestins);危险性评估(Risk Assessment)

DOI 10.1158/1055-9965.EPI-20-1355

PMID 33619020

发布时间 2025-05-30

基金项目

R01 CA136891/CA/NCI NIH HHS/United States R01 CA087538/CA/NCI NIH HHS/United States P50 CA105009/CA/NCI NIH HHS/United States K07 CA080668/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States R03 CA115195/CA/NCI NIH HHS/United States R01 CA054419/CA/NCI NIH HHS/United States R01 CA076016/CA/NCI NIH HHS/United States P01 CA017054/CA/NCI NIH HHS/United States R01 CA112523/CA/NCI NIH HHS/United States R01 CA126841/CA/NCI NIH HHS/United States N01 CN025403/CN/NCI NIH HHS/United States N01 PC067010/PC/NCI NIH HHS/United States P50 CA159981/CA/NCI NIH HHS/United States P30 CA046592/CA/NCI NIH HHS/United States M01 RR000056/RR/NCRR NIH HHS/United States R01 CA095023/CA/NCI NIH HHS/United States R03 CA113148/CA/NCI NIH HHS/United States R01 CA058598/CA/NCI NIH HHS/United States P30 CA014089/CA/NCI NIH HHS/United States R01 AG061132/AG/NIA NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交